Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 449 followers
Latest posts
Last updated 2 days ago
Human medicines European public assessment report (EPAR): Yaxwer, denosumab, Date of authorisation: 23/06/2025, Revision: 2, Status: Authorised
11 days ago
Human medicines European public assessment report (EPAR): Yaxwer, denosumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Vislyfa, ranibizumab, Date of authorisation: 15/07/2026, Revision: 1, Status: Authorised
5 days ago
Human medicines European public assessment report (EPAR): Vislyfa, ranibizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, Date of authorisation: 16/12/2019, Revision: 35, Status: Authorised
5 days ago
Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, Date of authorisation...
Human medicines European public assessment report (EPAR): Tagrisso, osimertinib, Date of authorisation: 01/02/2016, Revision: 25, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Tagrisso, osimertinib, Date of authorisation...
Human medicines European public assessment report (EPAR): Aybintio, bevacizumab, Date of authorisation: 19/08/2020, Revision: 13, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Aybintio, bevacizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Saphnelo, anifrolumab, Date of authorisation: 14/02/2022, Revision: 11, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Saphnelo, anifrolumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Vyloy, zolbetuximab, Date of authorisation: 19/09/2024, Revision: 5, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Vyloy, zolbetuximab, Date of authorisation...
Human medicines European public assessment report (EPAR): Repaglinide Accord, repaglinide, Date of authorisation: 22/12/2011, Revision: 8, Status: Withdrawn
2 days ago
Human medicines European public assessment report (EPAR): Repaglinide Accord, repaglinide, Date of...
Human medicines European public assessment report (EPAR): Emgality, galcanezumab, Date of authorisation: 14/11/2018, Revision: 15, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Emgality, galcanezumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Lynkuet, elinzanetant, Date of authorisation: 17/11/2025, Revision: 2, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Lynkuet, elinzanetant, Date of authorisation...
Veterinary medicines European public assessment report (EPAR): AviGate S. Typhimurium, Salmonella enterica, subsp. enterica, serovar Typhimurium, strain Nal2/Rif9/Rtt, Live, Status: Opinion
2 days ago
Veterinary medicines European public assessment report (EPAR): AviGate S. Typhimurium, Salmonella enterica...
Summary of opinion: Firocoxib CP-Pharma, 10/09/2026 Positive
2 days ago
Summary of opinion: Firocoxib CP-Pharma, 10/09/2026 Positive